Given these data, we hypothesized that a lipid‐specific autoimmune response may contribute to MS disease pathogenesis, and the characterization of CD1d quantitatively in different types of MS lesions would shed light on its relevance to the disease process. This evidence concerns the gene CD1D and myeloid sarcoma.